Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 211-220 of 271 for Lung cancer

Edit search filters
  1. A Multicenter Study In Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence For Rapid Lung Cancer Detection - The ON-SITE Study

    Jacksonville, FL

  2. A Study To Evaluate DNA Evaluation Of Fragments For Early Interception - Lung Cancer Training Study

    Rochester, MN

  3. Shared Decision-Making Encounter Tool For Decisions Of Adjuvant Treatment In Patients With Resected Non-Small Cell Lung Cancer

    Rochester, MN

  4. Preclinical drug testing and assay development for lung adenocarcinoma characterized by the expression of ASCL1

    Rochester, MN

  5. Profiling Of Lung Cancer For Identification Of Treatment Targets And Strategies

    Jacksonville, FL

  6. Collection of Lung Tumor Tissue for Current and Future Investigations into Lung Cancer Biology, Pathophysiology, and Epidemiology

    Jacksonville, FL

  7. Surgical Drain Fluid For Detection Of Molecular Residual Disease In Patients With Non-small Cell Lung Cancers

    Rochester, MN

  8. Alpha-1 AD Carriers and Lung Cancer Risk

    Rochester, MN

  9. Development of Novel Mutation Detection Methods for Lung Cancer

    Rochester, MN

  10. Determining the Special Gene Expressions in Patients with Lung Cancer or Mesothelioma

    Rochester, MN

.

Mayo Clinic Footer